Literature DB >> 21175666

HLA, immunogenetics, pharmacogenetics and personalized medicine.

D Charron1.   

Abstract

Displaying the highest level of diversity of any functional genetic complex with medical impact, the HLA system represents a landmark and a model for the development of predictive and preventive medicine. The massive amount of data which will soon be obtained through new high through put technologies for individual genomes and transcriptomes challenges the HLA and medicine paradigm. Systems biology approach and integrative methodologies will undoubtedly be needed to unravel the ever growing number of HLA and diseases associations and the role of immunogenetics in transplantation and other allogeneic cell therapies. Also HLA, immunogenetics and pharmacogenetics are merging to bring to the individual patient tailored and personalized treatment. Providing insights into the complexities of predictive, preventive participatory and personalized medicine, the role of the HLA system will be consolidated at the forefront of the newer medicine.
© 2010 The Author(s). Vox Sanguinis © 2010 International Society of Blood Transfusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175666     DOI: 10.1111/j.1423-0410.2010.01438.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  7 in total

1.  Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro.

Authors:  Wint Wah Lwin; Ken Park; Matthew Wauson; Qin Gao; Patricia W Finn; David Perkins; Ajai Khanna
Journal:  J Surg Res       Date:  2011-12-22       Impact factor: 2.192

2.  The deduced probable HLA-C*03:187-associated human leukocyte antigen haplotype (A*24:02-B*35:01-C*03:187-DRB1*11:01) revealed in Taiwanese unrelated hematopoietic bone marrow stem cell donors.

Authors:  Kuo-Liang Yang; Py-Yu Lin
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-30

3.  Molecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recovery.

Authors:  Feridoun Karimi-Busheri; Victoria Zadorozhny; Ewa Carrier; Habib Fakhrai
Journal:  Cell Tissue Bank       Date:  2012-05-18       Impact factor: 1.522

Review 4.  Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.

Authors:  Akash M Mehta; Merel Mooij; Ivan Branković; Sander Ouburg; Servaas A Morré; Ekaterina S Jordanova
Journal:  J Immunol Res       Date:  2017-02-09       Impact factor: 4.818

5.  HLA-A*29:01-B*07:05-C*15:29*DRB1*10:01-DQB1*05:01, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen-C low-incidence allele C*15:29 in Taiwanese individuals.

Authors:  Kuo-Liang Yang; Zheng-Zhong Zheng
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Apr-Jun

6.  Human leukocyte antigen-A*33:03-B*58:01-DRB1*15:140, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen low-incidence allele DRB1*15:140 in Taiwanese individuals: A case analysis.

Authors:  Kuo-Liang Yang; Zheng-Zhong Zheng
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Jan-Mar

7.  Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.

Authors:  Min Zhang; Wang-Dong Xu; Peng-Fei Wen; Yan Liang; Jie Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Vis       Date:  2013-09-12       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.